
|Articles|June 18, 2007
Latebreakers: Revision made of Actos label
A request from the FDA has led to a revision of the prescribing information for pioglitazone (Actos, Takeda Pharmaceuticals).
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
ACIP Vote Eliminates Universal Recommendation for Newborn Hepatitis B Vaccine
2
Trump Administration Looking to Bypass PBMs Through Online DTC Pharmacy
3
Pharmacists Now Authorized to Independently Prescribe Buprenorphine
4
Pharmacists Remain Health Care Focal Point as Vaccine Recommendations Change
5



































































































































